Novo Nordisk (NVO) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Novo Nordisk has announced the continuation of its ambitious 2024 share repurchase program, now initiating an additional buyback of up to DKK 3.14 billion. This move aims to reduce the company’s share capital and fulfill obligations from share-based incentive programs. The repurchase, which involves up to 400 million B shares, is set to occur between November 11, 2024, and February 3, 2025.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
